Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eyal Greenberg

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Pharmaceutical Design|February 1, 2014
MicroRNAs in cancer: lessons from melanomaEyal Greenberg, Yael Nemlich, Gal Markel
Oncotarget|July 10, 2015
miR-17 regulates melanoma cell motility by inhibiting the translation of ETV1Ronit Cohen, Eyal Greenberg, Yael Nemlich, et al.
Plos One|November 19, 2011
Mutagen-specific mutation signature determines global microRNA bindingEyal Greenberg, Gideon Rechavi, Ninette Amariglio, et al.
Open Biology|June 13, 2014
Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complexEyal Greenberg, Steven Hajdu, Yael Nemlich, et al.
Cancer Immunology, Immunotherapy : CII|May 31, 2018
Establishment of adoptive cell therapy with tumor infiltrating lymphocytes for non-small cell lung cancer patientsRonny Ben-Avi, Ronit Farhi, Alon Ben-Nun, et al.
Cancer Immunology, Immunotherapy : CII|November 17, 2020
microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapyGilli Galore-Haskel, Eyal Greenberg, Inbal Yahav, et al.
Plos One|March 2, 2013
Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanomaOrit Itzhaki, Eyal Greenberg, Bruria Shalmon, et al.
Plos One|May 5, 2011
Regulation of cancer aggressive features in melanoma cells by microRNAsEyal Greenberg, Liat Hershkovitz, Orit Itzhaki, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 2, 2013
A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: a pilot studyEyal Greenberg, Michal J Besser, Eytan Ben-Ami, et al.
Oncotarget|September 5, 2015
A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzymeGilli Galore-Haskel, Yael Nemlich, Eyal Greenberg, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Design|February 1, 2014
MicroRNAs in cancer: lessons from melanomaEyal Greenberg, Yael Nemlich, Gal Markel
Oncotarget|July 10, 2015
miR-17 regulates melanoma cell motility by inhibiting the translation of ETV1Ronit Cohen, Eyal Greenberg, Yael Nemlich, et al.
Plos One|November 19, 2011
Mutagen-specific mutation signature determines global microRNA bindingEyal Greenberg, Gideon Rechavi, Ninette Amariglio, et al.
Open Biology|June 13, 2014
Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complexEyal Greenberg, Steven Hajdu, Yael Nemlich, et al.
Cancer Immunology, Immunotherapy : CII|May 31, 2018
Establishment of adoptive cell therapy with tumor infiltrating lymphocytes for non-small cell lung cancer patientsRonny Ben-Avi, Ronit Farhi, Alon Ben-Nun, et al.
Cancer Immunology, Immunotherapy : CII|November 17, 2020
microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapyGilli Galore-Haskel, Eyal Greenberg, Inbal Yahav, et al.
Plos One|March 2, 2013
Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanomaOrit Itzhaki, Eyal Greenberg, Bruria Shalmon, et al.
Plos One|May 5, 2011
Regulation of cancer aggressive features in melanoma cells by microRNAsEyal Greenberg, Liat Hershkovitz, Orit Itzhaki, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 2, 2013
A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: a pilot studyEyal Greenberg, Michal J Besser, Eytan Ben-Ami, et al.
Oncotarget|September 5, 2015
A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzymeGilli Galore-Haskel, Yael Nemlich, Eyal Greenberg, et al.
Pageof 2